Luca Durelli

Luca Durelli

UNVERIFIED PROFILE

Are you Luca Durelli?   Register this Author

Register author
Luca Durelli

Luca Durelli

Publications by authors named "Luca Durelli"

Are you Luca Durelli?   Register this Author

32Publications

477Reads

7Profile Views

Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS.

Mult Scler 2019 04 20;25(4):591-600. Epub 2018 Mar 20.

Service de Neurologie A, Hôpital Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France/Observatoire Français de la Sclérose en Plaques (OFSEP), Lyon, France/Centre de Recherche en Neurosciences de Lyon, INSERM U1028, CNRS UMR5292, Equipe Neuro-Oncologie et Neuro-Inflammation, Lyon, France/Université de Lyon 1, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458518763080DOI Listing
April 2019

Lack of CD4+ T cell percent decrease in alemtuzumab-treated multiple sclerosis patients with persistent relapses.

J Neuroimmunol 2017 12 17;313:89-91. Epub 2017 Oct 17.

Clinical and Biological Sciences Department, University of Torino, San Luigi Gonzaga Hospital, Orbassano (TO), Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2017.10.009DOI Listing
December 2017

Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis.

Expert Opin Drug Saf 2017 Aug 5;16(8):963-972. Epub 2017 Jul 5.

a Clinical and Biological Sciences Department , University of Torino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14740338.2017.1346082DOI Listing
August 2017

Active CMV infection in two patients with multiple sclerosis treated with alemtuzumab.

Mult Scler 2017 05 1;23(6):874-876. Epub 2017 Feb 1.

Department of Neurology, Washington University, St. Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458516688350DOI Listing
May 2017

Natalizumab in Multiple Sclerosis: Long-Term Management.

Int J Mol Sci 2017 Apr 29;18(5). Epub 2017 Apr 29.

Clinical and Biological Sciences Department, University of Torino, Orbassano (TO) 10043, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms18050940DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454853PMC
April 2017

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea.

J Vis Exp 2016 11 9(117). Epub 2016 Nov 9.

Clinical and Biological Sciences Department, Neurology Unit, University of Torino, San Luigi Gonzaga Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3791/54606DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226147PMC
November 2016

Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months.

Neurol Neuroimmunol Neuroinflamm 2016 Feb 21;3(1):e194. Epub 2016 Jan 21.

Division of Neurology (S.D.M., S.R., A.C., L.D., M.C.) and the Department of Clinical and Biological Sciences (S.D.M., A.C., L.D., M.C.), University of Torino, San Luigi Gonzaga University Hospital, Orbassano; Center for Experimental Research and Medical Studies (CERMS) (S.R., V.B., F.N.), Azienda Ospedaliera Città della Salute e della Scienza di Torino; Department of Molecular Biotechnology and Health Sciences (V.B., F.N.), Università degli Studi di Torino; Multiple Sclerosis Center (E.C.), Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Italy; Department of Neurology (A.V., S.S.-B.), Clinical Hospital Sveti Duh Zagreb; Medical Faculty University (A.V., S.S.-B.), J.J. Strossmayer Osijek; Department of Neurology (M.H., I.A.), Referral Center for Demyelinating Diseases of the Central Nervous System, University Hospital Center Zagreb, Croatia; Department of Neurology and Center of Clinical Neuroscience (D.H.), Charles University in Prague, First Faculty of Medicine and General University Hospital, Czech Republic; and Multiple Sclerosis Study Center (P.A.), AO S. Antonio Abate, Gallarate (VA), Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000194DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723135PMC
February 2016

Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course: A Report from an International CMSC Consensus Conference, March 5-7, 2010.

Int J MS Care 2012 ;14(3):105-14

University of Medicine and Dentistry of New Jersey, Newark, NJ, USA (SDC); Department of Neurology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, NJ (SDJ); VA Medical Center-East Orange, East Orange, NJ, USA (PD); Department of Clinical and Biological Sciences, San Luigi Gonzaga Medical School, University of Torino, Orbassano, Italy (LD); Multiple Sclerosis Clinic, University of New Mexico Health Sciences Center, Albuquerque, NM, USA (CF); Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, Whitechapel, London, UK (GG); Consortium of Multiple Sclerosis Centers, Hackensack, NJ, USA (J Halper); Multiple Sclerosis Clinic, Foothills Medical Centre, Calgary, Alberta, Canada (CH); MS Comprehensive Care Center, NYU Langone Medical Center, New York, NY, USA (J Herbert); MS Clinic, University of British Columbia Hospital, Vancouver, British Columbia, Canada (DL); MS Research Group, University of Texas Health, Houston, TX, USA (JAL); Comprehensive Clinical and Research MS Center, Wayne State University, Detroit, MI, USA (RL); Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Mount Sinai School of Medicine, New York, NY, USA (FDL); Department of Neurology, Mayo Clinic, Rochester, MN, USA (CFL); Vancouver General Hospital, Vancouver, British Columbia, Canada (WM); Department of Neurology, Washington University, St. Louis, MO, USA (RTN); LACTRIMS and Institute of Neurology, Montevideo, Uruguay (CO); VA Medical Center, Portland, OR, USA (JS); and Biostatistics Unit, Department of Health Sciences, University of Genoa, Genoa, Italy (MPS).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7224/1537-2073-14.3.105DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882992PMC
January 2014

Pro-inflammatory cytokine and chemokine mRNA blood level in multiple sclerosis is related to treatment response and interferon-beta dose.

J Neuroimmunol 2010 Sep 23;226(1-2):150-7. Epub 2010 Jun 23.

University Division of Neurology, Facolta' San Luigi Gonzaga, Universita' di Torino, Ospedale Universitario San Luigi Gonzaga, Regione Gonzole, 10, I-10043 Orbassano, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2010.05.038DOI Listing
September 2010

T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta.

Ann Neurol 2009 May;65(5):499-509

Department of Clinical and Biological Sciences, Division of Neurology, San Luigi Gonzaga School of Medicine, Orbassano (Torino), Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.21652DOI Listing
May 2009

The therapy of multiple sclerosis with immune-modulating or immunosuppressive drug. A critical evaluation based upon evidence based parameters and published systematic reviews.

Clin Neurol Neurosurg 2008 Nov 4;110(9):878-85. Epub 2008 Mar 4.

Dipartimento di Scienze Cliniche e Biologiche, Divisione di Neurologia, Ospedale Universitario, S.Luigi Gonzaga, Universita' di Torino, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clineuro.2007.10.020DOI Listing
November 2008

The OPTimization of interferon for MS study: 375 microg interferon beta-1b in suboptimal responders.

J Neurol 2008 Sep 25;255(9):1315-23. Epub 2008 Sep 25.

Dipartimento di Scienze Cliniche, e Biologiche, Universita' di Torino, Divisione di Neurologia, Ospedale Universitario S. Luigi Gonzaga, Regione Gonzole, 10, 10043, Orbassano (Torino), Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-008-0879-6DOI Listing
September 2008

Adherence to interferon-beta treatment and results of therapy switching.

J Neurol Sci 2007 Aug 21;259(1-2):104-8. Epub 2007 Mar 21.

Divisione Universitaria di Neurologia, Ospedale Clinicizzato San Luigi Gonzaga, Dipartimento di Scienze Cliniche e Biologiche, Universita' di Torino, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2006.05.075DOI Listing
August 2007

Interferon-beta1a for the treatment of multiple sclerosis.

Expert Opin Biol Ther 2007 Apr;7(4):535-42

Divisione Universitaria di Neurologia, Ospedale Clinicizzato San Luigi Gonzaga, Dipartimento di Scienze Cliniche e Biologiche, Università di Torino, Regione Gonzole 10, I-10043 Orbassano, TO, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.7.4.535 DOI Listing
April 2007

The importance of maintaining effective therapy in multiple sclerosis.

J Neurol 2005 Sep;252 Suppl 3:iii38-iii43

University Division of Neurology, San Luigi Gonzaga University Hospital, Regione Gonzole, 10, 10043 Orbassano (Torino), Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-005-2016-0DOI Listing
September 2005

Anti-interferon antibodies in multiple sclerosis. Molecular basis and their impact on clinical efficacy.

Front Biosci 2004 Sep 1;9:2192-204. Epub 2004 Sep 1.

University Division of Neurology, S. Luigi Gonzaga Hospital, Regione Gonzole, 10, I-10043 Orbassano, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2741/1329DOI Listing
September 2004

Is multiple sclerosis a disease that requires frequent beta interferon dosing?

Authors:
Luca Durelli

J Neurol 2004 Sep;251 Suppl 4:IV13-24

Department of Neuroscience, University of Turin, 10126, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-004-1404-1DOI Listing
September 2004

Dose and frequency of interferon treatment matter--INCOMIN and OPTIMS.

Authors:
Luca Durelli

J Neurol 2003 Dec;250 Suppl 4:IV9-IV14

Department of Neuroscience, University of Turin, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-003-1403-7DOI Listing
December 2003

Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP.

J Neurol 2002 Jun;249(6):719-22

U. O. A. D. U. Neurologia I, Dipartimento di Neuroscienze, Università di Torino, Via Cherasco 15, 10126 Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-002-0698-0DOI Listing
June 2002